Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

NCT02801487 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Slow accrual of patients.

Conditions

Nasopharyngeal Carcinoma

Interventions

RADIATION: Carbon ion radiotherapy (CIRT)
DRUG: Cisplatin

Sponsor

Shanghai Proton and Heavy Ion Center